Preclinical News and Research

RSS
BerGenBio completes $8.8M Series A financing round

BerGenBio completes $8.8M Series A financing round

Colby's JVRS-100 enhances immunogenicity, cross-protective efficacy of H5N1 influenza vaccine

Colby's JVRS-100 enhances immunogenicity, cross-protective efficacy of H5N1 influenza vaccine

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

Silence completes siRNA research work with AstraZeneca, MedImmune

Silence completes siRNA research work with AstraZeneca, MedImmune

Alnylam files CTA with the U.K. MHRA to initiate ALN-TTR02 Phase I trial in ATTR

Alnylam files CTA with the U.K. MHRA to initiate ALN-TTR02 Phase I trial in ATTR

Clearside Biomedical receives $4M venture capital investment

Clearside Biomedical receives $4M venture capital investment

Celtaxsys announces acquisition of CTX-4430 from Estrellita

Celtaxsys announces acquisition of CTX-4430 from Estrellita

Tetragenetics reports results from G-SOME H5N1 vaccine preclinical study

Tetragenetics reports results from G-SOME H5N1 vaccine preclinical study

CRF sponsors Seventh International Conference on Cell Therapy for Cardiovascular Disease

CRF sponsors Seventh International Conference on Cell Therapy for Cardiovascular Disease

Ipsen, Oncodesign partner to discover and develop LRRK2 kinase inhibitors against PD

Ipsen, Oncodesign partner to discover and develop LRRK2 kinase inhibitors against PD

Midatech raises £6.3M through private investment round

Midatech raises £6.3M through private investment round

Novel vaccine combinations can protect against infection by SIV

Novel vaccine combinations can protect against infection by SIV

Article focuses on new optical tools that use laser beams to peer painlessly below the skin

Article focuses on new optical tools that use laser beams to peer painlessly below the skin

Probiodrug secures EUR 15M for clinical development of PQ912

Probiodrug secures EUR 15M for clinical development of PQ912

Itamar, Roche to further develop EndoPAT technology for pre-clinical trials

Itamar, Roche to further develop EndoPAT technology for pre-clinical trials

Bionomics, Ironwood partner to develop and commercialize novel anti-anxiety compound

Bionomics, Ironwood partner to develop and commercialize novel anti-anxiety compound

NGP receives investment from Abbott to develop NGP 555 for AD

NGP receives investment from Abbott to develop NGP 555 for AD

Viamet commences VT-464 Phase 1/2 trial in castration-refractory prostate cancer

Viamet commences VT-464 Phase 1/2 trial in castration-refractory prostate cancer

Task force identifies key themes and challenges in critical care research

Task force identifies key themes and challenges in critical care research

Antigen Express to move AE37 cancer vaccine into larger clinical trials

Antigen Express to move AE37 cancer vaccine into larger clinical trials

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.